Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2392-2402

  Talreja, Deepa ^a,b   Kaye, Keith S ^c   Yu, Fu Shin ^a,c   Walia, Satish K ^b   Kumar, Ashok ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Cell death; Endophthalmitis; Inflammation; Innate response

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAM; CD45 ANTIGEN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CHLORPHENIRAMINE; CIPROFLOXACIN; COTRIMOXAZOLE; CXCL2 CHEMOKINE; GENTAMICIN; IMIPENEM; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEROPENEM; MOXIFLOXACIN; NITROFURANTOIN; QUINOLONE DERIVATIVE; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BIOFILM; CELL DEATH; CYTOTOXICITY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; INFANT; MOUSE; NEUTROPHIL; NICK END LABELING; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BACTERIA; CELL DEATH; ENDOPHTHALMITIS; INFLAMMATION; INNATE RESPONSE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FLOW CYTOMETRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RNA, BACTERIAL; SEVERITY OF ILLNESS INDEX;

EID: 84898918728     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13401     Document Type: Article

References (60)

1. Eveillard M, Kempf M, Belmonte O, Pailhories H, Joly-Guillou ML. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013;17: e802-e805.
2. Tayabali AF, Nguyen KC, Shwed PS, Crosthwait J, Coleman G, Seligy VL. Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources. PLoS One. 2012;7:e37024.
3. Clemente WT, Sanches MD, Coutinho RL, et al. Multidrugresistant Acinetobacter baumannii causing necrotizing fasciitis in a pancreas-kidney transplant recipient: a case report. Transplantation. 2012;94:e37-e38.
4. Charnot-Katsikas A, Dorafshar AH, Aycock JK, David MZ, Weber SG, Frank KM. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol. 2009;47:258-263.
5. Yang M, Hu Z, Hu F. Nosocomial meningitis caused by Acinetobacter baumannii: risk factors and their impact on patient outcomes and treatments. Future Microbiol. 2012;7: 787-793.
6. Munoz-Price LS, Weinstein RA. Acinetobacter Infection. N Engl J Med. 2008;358:1271-1281.
7. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939-951.
8. Jimenez-Mejias ME, Pachon J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M. Treatment of multidrugresistant Acinetobacter baumannii meningitis with ampicillin/ sulbactam. Clin Infect Dis. 1997;24:932-935.
9. Cisneros JM, Reyes MJ, Pachon J, et al. Bacteremia due to Acinetobacter baumannii epidemiology, clinical findings, and prognostic features. Clin Infect Dis. 1996;22:1026-1032.
10. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868-873.
11. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2005;11:22-29.
12. Neidell MJ, Cohen B, Furuya Y, et al. Costs of healthcare-and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55:807-815.
13. Cerqueira GM, Peleg AY. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life. 2011;63:1055-1060.
14. Callegan MC, Gilmore MS, Gregory M, et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res. 2007;26:189-203.
15. Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31:316-331.
16. de Caro JJ, Ta CN, Ho HK, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina. 2008;28:877-883.
17. Stewart JM, Srivastava SK, Fung AE, et al. Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011;19:32-38.
18. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98: 639-649, discussion 50.
19. CDC. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention. 2013. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed October 5, 2013.
20. Mortensen BL, Skaar EP. Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol. 2012;14:1336-1344.
21. McConnell MJ, Actis L, Pachon J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013;37:130-155.
22. Chen KJ, Hou CH, Sun MH, Lai CC, Sun CC, Hsiao CH. Endophthalmitis caused by Acinetobacter baumannii: report of two cases. J Clin Microbiol. 2008;46:1148-1150.
23. Bitirgen G, Ozkagnici A, Kerimoglu H, Kamis U. Acute postoperative endophthalmitis with an unusual infective agent: Acinetobacter baumannii. J Cataract Refract Surg. 2013;39:143-144.
24. Roy R, Panigrahi P, Malathi J, et al. Endophthalmitis caused by Acinetobacter baumannii: a case series. Eye (Lond). 2013;27: 450-452.
25. Reddy T, Chopra T, Marchaim D, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother. 2010;54:2235-2238.
26. Talreja D, Muraleedharan C, Gunathilaka G, Zhang Y, Kaye KS, Walia SK, AK Virulence properties of multidrug resistant ocular isolates of Acinetobacter baumannii [published online ahead of print February 6, 2014]. Curr Eye Res. doi:10.3109/ 02713683.2013.873055.
27. Kumar A, Singh CN, Glybina IV, Mahmoud TH, Yu FS. Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J Infect Dis. 2010;201:255-263.
28. Whiston EA, Sugi N, Kamradt MC, et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 2008;76:1781-1790.
29. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006;31:955-965.
30. Kochan T, Singla A, Tosi J, Kumar A. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect Immun. 2012;80:2076-2088.
31. Skeie JM, Tsang SH, Mahajan VB. Evisceration of mouse vitreous and retina for proteomic analyses. J Vis Exp. 2011;pii: 2795.
32. Perez LRR, Barth AL. Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosa. Braz J Infect Dis. 2011;15:301-304.
33. Ramadan RT, Moyer AL, Callegan MC. A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest Ophthalmol Vis Sci. 2008;49: 4482-4489.
34. Hunt JJ, Wang JT, Callegan MC. Contribution of mucoviscosityassociated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2011;52:6860-6866.
35. Al-Ubaidi MR, Matsumoto H, Kurono S, Singh A. Proteomics profiling of the cone photoreceptor cell line, 661W. Adv Exp Med Biol. 2008;613:301-311.
36. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868-873.
37. Giese MJ, Rayner SA, Fardin B, et al. Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2003;44:3077-3082.
38. Kumar A, Yu FS. Toll-like receptors and corneal innate immunity. Curr Mol Med. 2006;6:327-337.
39. Kumar A, Pandey RK, Miller LJ, Singh PK, Kanwar M. Müller glia in retinal innate immunity: a perspective on their roles in endophthalmitis. Crit Rev Immunol. 2013;33:119-135.
40. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471-3484.
41. McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36:1588-1598.
42. Maltezou HC, Pappa O, Nikolopoulos G, et al. Postcataract surgery endophthalmitis outbreak caused by multidrug-resistant Pseudomonas aeruginosa. Am J Infect Control. 2012;40: 75-77.
43. Pathengay A, Moreker MR, Puthussery R, et al. Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India. Retina. 2011;31: 1806-1811.
44. Chuang YY, Huang YC, Lin CH, Su LH, Wu CT. Epidemiological investigation after hospitalising a case with pandrug-resistant Acinetobacter baumannii infection. J Hosp Infect. 2009;72: 30-35.
45. Schmidt ME, Smith MA, Levy CS. Endophthalmitis caused by unusual gram-negative bacilli: three case reports and review. Clin Infect Dis. 1993;17:686-690.
46. Mayer-Scholl A, Averhoff P, Zychlinsky A. How do neutrophils and pathogens interact? Curr Opin Microbiol. 2004;7:62-66.
47. Cooper PR, Palmer LJ, Chapple IL. Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe? Periodontol 2000. 2013;63:165-197.
48. Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197-223.
49. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376.
50. Petropoulos IK, Vantzou CV, Lamari FN, Karamanos NK, Anastassiou ED, Pharmakakis NM. Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slimepositive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch Clin Exp Ophthalmol. 2006;244:1322-1328.
51. Ming WJ, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987;138:1469-1474.
52. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484-489.
53. Kumar A, Yin J, Zhang J, Yu FS. Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci. 2007;48: 4664-4670.
54. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci. 2004;45:3513-3522.
55. Park PJ, Shukla D. Role of heparan sulfate in ocular diseases. Exp Eye Res. 2013;110:1-9.
56. Hoiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011;3:55-65.
57. Nucleo E, Fugazza G, Migliavacca R, et al. Differences in biofilm formation and aggregative adherence between betalactam susceptible and beta-lactamases producing P. mirabilis clinical isolates. New Microbiol. 2010;33:37-45.
58. Simoes LC, Simoes M, Vieira MJ. Adhesion and biofilm formation on polystyrene by drinking water-isolated bacteria. Antonie Van Leeuwenhoek. 2010;98:317-329.
59. Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Arch Ophthalmol. 2008;126:1572-1581.
60. Suzuki T, Uno T, Kawamura Y, Joko T, Ohashi Y. Postoperative low-grade endophthalmitis caused by biofilm-producing coccus bacteria attached to posterior surface of intraocular lens. J Cataract Refract Surg. 2005;31:2019-2020.